Women who undergo cancer treatment expect that their hair might fall out, but are told that it will grow back a few months after therapy ends. They also expect that, if a certain chemo drug presents an abnormally high risk for irreversible hair loss, that they will be informed of this side effect so that they can make an informed health care decision.
But in the case of Taxotere—which studies show is more likely than similar, equally effective chemotherapy agents to result in permanent alopecia—women were never given this choice, because they were not warned about alopecia side effects. If you are suffering from such a situation , you can take the legal advice from the best taxotere lawsuits.
Women suffering from chemotherapy-related hair loss have reported that, even though they recovered from cancer, they have not made a full recovery due to their baldness. The psychological impact of hair loss affects both genders, but women are especially hard hit. Doctors theorize that these feelings are due to societal beauty standards towards women.
They say that hair loss has left them feeling self-conscious, unattractive, and socially crippled. Some women have even said they’d rather lose a breast to cancer than lose their hair.
The Taxotere lawsuits allege that drugmaker Sanofi:
- Knew, or should have known, about Taxotere alopecia side effects and provided proper warnings.
- Did not adequately test Taxotere to determine its risks.
- Was negligent in its design, manufacture, and marketing of Taxotere.
- Sold an unsafe, defective, and inherently dangerous drug.
- Had a duty to create a product that was not unreasonably dangerous when used as intended.
- Caused plaintiffs to suffer permanent alopecia as a result of its acts and omissions.